ADVFN US – Market Content Editor

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) said it has named Debra K. Osteen as chief executive officer with immediate effect. Osteen, who previously led the company and served on its board, replaces Chris Hunter, who is stepping down from both management and the board. Osteen was Acadia’s CEO from December 2018 until March 2022 and continued…

Oil prices moved modestly higher on Tuesday, supported by stronger-than-anticipated economic data from China, although advances were restrained as markets remained cautious following renewed trade tariff threats from the Trump administration toward several European countries linked to the Greenland dispute. At 08:05 ET (13:05 GMT), Brent crude futures for March delivery were up 0.8% at…

Corvus Pharmaceuticals (NASDAQ:CRVS) shares surged 48% on Tuesday after the company released positive findings from a Phase 1 clinical study of its oral drug candidate soquelitinib in atopic dermatitis. The clinical-stage biotech said cohort 4 of its randomized, double-blind, placebo-controlled trial delivered safety and efficacy outcomes that were consistent with — and in some cases…

Fastenal Company (NASDAQ:FAST) said on Tuesday that its fourth-quarter earnings met market expectations, but revenue fell just short of forecasts, sending the stock lower. Shares in the industrial and construction supplies distributor dropped 4.21% in pre-market trading following the results. Fastenal reported earnings of $0.26 per share for the quarter ended December 31, 2025, in…

Forestar Group Inc. (NYSE:FOR) said on Tuesday that first-quarter fiscal 2026 revenue climbed 9% year on year to $273 million, topping analyst expectations of $265.48 million. Earnings per share, however, came in at $0.30, missing the consensus forecast of $0.32. Shares were little changed following the release, edging up just 0.07%. Net income for the…

Boundless Bio (NASDAQ:BOLD) said it has received clearance from the Food and Drug Administration for its investigational new drug application covering BBI-940, paving the way for a clinical trial of the experimental therapy. The company plans to initiate the KOMODO-1 study in the first half of 2026, enrolling patients with metastatic breast cancer. The San…

Fifth Third Bancorp (NASDAQ:FITB) reported fourth-quarter results on Tuesday that came in ahead of analyst expectations, with profit attributable to common shareholders climbing 20% year on year to $699 million, or $1.04 per diluted share. Shares of the regional lender rose 1.71% in pre-market trading following the announcement. The stronger performance was supported by improving…

D.R. Horton (NYSE:DHI) reported fiscal first-quarter net sales orders below market expectations, highlighting continued pressure on homebuying activity as consumers remain cautious. Rising housing costs and elevated mortgage rates have weighed heavily on affordability for U.S. buyers, an issue that has also moved into sharper focus ahead of the November midterm elections. Against this backdrop,…

3M Co. (NYSE:MMM) said on Tuesday that it delivered fourth-quarter adjusted earnings ahead of expectations and issued an outlook pointing to continued growth in 2026. The group reported adjusted earnings per share of $1.83 for the quarter, above the $1.80 consensus estimate, while revenue reached $6.1 billion, also beating forecasts of $6.01 billion. Shares slipped…